Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Docebo (DCBO) Other Non Operating Income (2019 - 2025)

Historic Other Non Operating Income for Docebo (DCBO) over the last 7 years, with Q2 2025 value amounting to -$1000.0.

  • Docebo's Other Non Operating Income rose 9285.71% to -$1000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was -$2.0 million, marking a year-over-year decrease of 20550.36%. This contributed to the annual value of -$2.4 million for FY2024, which is 15432.8% down from last year.
  • Docebo's Other Non Operating Income amounted to -$1000.0 in Q2 2025, which was up 9285.71% from -$189000.0 recorded in Q1 2025.
  • Docebo's 5-year Other Non Operating Income high stood at $4.4 million for Q2 2023, and its period low was -$4.8 million during Q3 2021.
  • Moreover, its 5-year median value for Other Non Operating Income was -$8000.0 (2023), whereas its average is $334888.9.
  • As far as peak fluctuations go, Docebo's Other Non Operating Income plummeted by 472894.74% in 2022, and later soared by 1989545.45% in 2023.
  • Quarter analysis of 5 years shows Docebo's Other Non Operating Income stood at -$38000.0 in 2021, then crashed by 4728.95% to -$1.8 million in 2022, then skyrocketed by 264.85% to $3.0 million in 2023, then crashed by 160.86% to -$1.8 million in 2024, then soared by 99.95% to -$1000.0 in 2025.
  • Its Other Non Operating Income was -$1000.0 in Q2 2025, compared to -$189000.0 in Q1 2025 and -$1.8 million in Q4 2024.